Inflammatory and Infectious Diseases Symposium

Related

• 

  The Changing Avastin Landscape

  Paul Hahn, MD, PhD, FASRS

  Annual Meeting Talks

  2019

• 

  2 Real-World Analyses of Treatment Burden Associated With Intravitreal Injections for DME Prior to 0.2 mcg/Day Fluocinolone Acetonide (FAc)

  Nancy M. Holekamp, MD, FASRS

  Annual Meeting Talks

  2018

• 

  Injectable Fluocinolone Acetonide Intravitreal Insert Reduces the Need for Adjunctive Treatment in Noninfectious Posterior Segment Uveitis

  Sunil Srivastava, MD

  Annual Meeting Talks

  2018